Smitha Kizhake

634 total citations
20 papers, 490 citations indexed

About

Smitha Kizhake is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Smitha Kizhake has authored 20 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Smitha Kizhake's work include RNA and protein synthesis mechanisms (4 papers), Protein Structure and Dynamics (3 papers) and Advanced Breast Cancer Therapies (3 papers). Smitha Kizhake is often cited by papers focused on RNA and protein synthesis mechanisms (4 papers), Protein Structure and Dynamics (3 papers) and Advanced Breast Cancer Therapies (3 papers). Smitha Kizhake collaborates with scholars based in United States, Canada and France. Smitha Kizhake's co-authors include Amarnath Natarajan, Sandeep Rana, Muhammad Zahid, Smit Kour, Mourad Bendjennat, Jacob I. Contreras, Prakash Radhakrishnan, Yogesh A. Sonawane, Ramandeep Rattan and Tianhua Zhou and has published in prestigious journals such as Journal of Biological Chemistry, Chemical Communications and Scientific Reports.

In The Last Decade

Smitha Kizhake

20 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Smitha Kizhake United States 14 310 162 132 71 42 20 490
Jacob I. Contreras United States 10 344 1.1× 195 1.2× 124 0.9× 85 1.2× 61 1.5× 12 536
Eva Řezníčková Czechia 15 259 0.8× 146 0.9× 245 1.9× 85 1.2× 35 0.8× 44 541
Sarah Diab Australia 14 325 1.0× 177 1.1× 117 0.9× 103 1.5× 29 0.7× 19 522
Brian Zifcak United States 7 431 1.4× 136 0.8× 125 0.9× 45 0.6× 17 0.4× 10 570
Henrik Moebitz Switzerland 5 325 1.0× 119 0.7× 105 0.8× 30 0.4× 42 1.0× 8 441
Min‐Wu Chao Taiwan 15 364 1.2× 149 0.9× 86 0.7× 31 0.4× 26 0.6× 26 492
Pascal Furet Switzerland 7 397 1.3× 247 1.5× 189 1.4× 41 0.6× 41 1.0× 7 565
Angela Hayes United Kingdom 15 484 1.6× 259 1.6× 75 0.6× 69 1.0× 73 1.7× 33 659
Edward J. Lewis United Kingdom 5 223 0.7× 150 0.9× 46 0.3× 77 1.1× 40 1.0× 5 360
David Bartkovitz United States 7 427 1.4× 356 2.2× 118 0.9× 43 0.6× 69 1.6× 7 604

Countries citing papers authored by Smitha Kizhake

Since Specialization
Citations

This map shows the geographic impact of Smitha Kizhake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Smitha Kizhake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Smitha Kizhake more than expected).

Fields of papers citing papers by Smitha Kizhake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Smitha Kizhake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Smitha Kizhake. The network helps show where Smitha Kizhake may publish in the future.

Co-authorship network of co-authors of Smitha Kizhake

This figure shows the co-authorship network connecting the top 25 collaborators of Smitha Kizhake. A scholar is included among the top collaborators of Smitha Kizhake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Smitha Kizhake. Smitha Kizhake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rana, Sandeep, Smit Kour, Smitha Kizhake, et al.. (2022). Dimers of isatin derived α-methylene-γ-butyrolactone as potent anti-cancer agents. Bioorganic & Medicinal Chemistry Letters. 65. 128713–128713. 7 indexed citations
2.
Kour, Smit, Sandeep Rana, Smitha Kizhake, et al.. (2022). Spirocyclic dimer SpiD7 activates the unfolded protein response to selectively inhibit growth and induce apoptosis of cancer cells. Journal of Biological Chemistry. 298(5). 101890–101890. 8 indexed citations
3.
Singh, Sarbjit, Jayapal Reddy Mallareddy, Yogesh A. Sonawane, et al.. (2021). Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy. European Journal of Medicinal Chemistry. 222. 113579–113579. 13 indexed citations
4.
Rana, Sandeep, Jayapal Reddy Mallareddy, Smitha Kizhake, et al.. (2021). Aminopyrazole based CDK9 PROTAC sensitizes pancreatic cancer cells to venetoclax. Bioorganic & Medicinal Chemistry Letters. 43. 128061–128061. 45 indexed citations
5.
Kour, Smit, Sandeep Rana, Smitha Kizhake, et al.. (2021). Stapling proteins in the RELA complex inhibits TNFα-induced nuclear translocation of RELA. RSC Chemical Biology. 3(1). 32–36. 7 indexed citations
6.
Singh, Sarbjit, Sandeep Rana, Mourad Bendjennat, et al.. (2021). Small molecule binding to inhibitor of nuclear factor kappa-B kinase subunit beta in an ATP non-competitive manner. Chemical Communications. 57(38). 4678–4681. 5 indexed citations
7.
Rana, Sandeep, Smit Kour, Yogesh A. Sonawane, et al.. (2020). Symbiotic prodrugs (SymProDs) dual targeting of NFkappaB and CDK. Chemical Biology & Drug Design. 96(2). 773–784. 13 indexed citations
8.
Robb, Caroline M., Smit Kour, Jacob I. Contreras, et al.. (2020). Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 11(25). 2462–2463. 3 indexed citations
9.
Rana, Sandeep, Mourad Bendjennat, Smit Kour, et al.. (2019). Selective degradation of CDK6 by a palbociclib based PROTAC. Bioorganic & Medicinal Chemistry Letters. 29(11). 1375–1379. 108 indexed citations
10.
Kour, Smit, Sandeep Rana, Jacob I. Contreras, et al.. (2019). CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax. Molecular Pharmacology. 96(4). 419–429. 21 indexed citations
11.
Rana, Sandeep, Yogesh A. Sonawane, Margaret Taylor, et al.. (2018). Synthesis of aminopyrazole analogs and their evaluation as CDK inhibitors for cancer therapy. Bioorganic & Medicinal Chemistry Letters. 28(23-24). 3736–3740. 18 indexed citations
12.
Robb, Caroline M., Smit Kour, Jacob I. Contreras, et al.. (2017). Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 9(4). 5216–5232. 25 indexed citations
13.
14.
Rana, Sandeep, Calvin Tebbe, Jacob I. Contreras, et al.. (2016). Isatin Derived Spirocyclic Analogues with α-Methylene-γ-butyrolactone as Anticancer Agents: A Structure–Activity Relationship Study. Journal of Medicinal Chemistry. 59(10). 5121–5127. 98 indexed citations
15.
Kizhake, Smitha, et al.. (2013). The paradox of conformational constraint in the design of Cbl(TKB)-binding peptides. Scientific Reports. 3(1). 1639–1639. 18 indexed citations
16.
Palermo, Nicholas Y., Lin Dong, Gulzar Ahmad, et al.. (2012). Peptide Truncation Leads to a Twist and an Unusual Increase in Affinity for Casitas B-Lineage Lymphoma Tyrosine Kinase Binding Domain. Journal of Medicinal Chemistry. 55(7). 3583–3587. 10 indexed citations
17.
Campbell, Stephen J., et al.. (2011). Exploiting the P-1 Pocket of BRCT Domains Toward a Structure Guided Inhibitor Design. ACS Medicinal Chemistry Letters. 2(10). 764–767. 20 indexed citations
18.
Kizhake, Smitha, et al.. (2011). Structure–Activity Relationship Studies To Probe the Phosphoprotein Binding Site on the Carboxy Terminal Domains of the Breast Cancer Susceptibility Gene 1. Journal of Medicinal Chemistry. 54(12). 4264–4268. 15 indexed citations
19.
Anisimov, Victor M., et al.. (2011). Computational and experimental studies of the interaction between phospho-peptides and the C-terminal domain of BRCA1. Journal of Computer-Aided Molecular Design. 25(11). 1071–1084. 25 indexed citations
20.
Joseph, Prem Raj B., et al.. (2010). Structural characterization of BRCT–tetrapeptide binding interactions. Biochemical and Biophysical Research Communications. 393(2). 207–210. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacob I. Contreras Breakdown of academic impact, for papers by Eva Řezníčková Breakdown of academic impact, for papers by Sarah Diab Breakdown of academic impact, for papers by Brian Zifcak Breakdown of academic impact, for papers by Henrik Moebitz Breakdown of academic impact, for papers by Min‐Wu Chao Breakdown of academic impact, for papers by Pascal Furet Breakdown of academic impact, for papers by Angela Hayes Breakdown of academic impact, for papers by Edward J. Lewis Breakdown of academic impact, for papers by David Bartkovitz
Rankless by CCL
2026